|
🐜
|
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
13 auth.
B. Coiffier,
É. Lepage,
J. Brière,
R. Herbrecht,
H. Tilly,
R. Bouabdallah,
P. Morel,
E. Van Den Neste,
G. Salles,
P. Gaulard,
...
F. Reyes,
P. Lederlin,
C. Gisselbrecht
|
11 |
2002 |
11
🐜
|
|
🐜
|
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
16 auth.
P. Feugier,
A. Hoof,
C. Sebban,
P. Solal-Céligny,
R. Bouabdallah,
C. Fermé,
B. Christian,
É. Lepage,
H. Tilly,
F. Morschhauser,
...
P. Gaulard,
G. Salles,
A. Bosly,
C. Gisselbrecht,
F. Reyes,
B. Coiffier
|
10 |
2005 |
10
🐜
|
|
🐜
|
Single versus double autologous stem-cell transplantation for multiple myeloma.
14 auth.
M. Attal,
J. Harousseau,
T. Facon,
F. Guilhot,
C. Doyen,
J. Fuzibet,
M. Monconduit,
C. Hulin,
D. Caillot,
R. Bouabdallah,
...
L. Voillat,
J. Sotto,
B. Grosbois,
R. Bataille
|
9 |
2003 |
9
🐜
|
|
🐜
|
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
30 auth.
G. Salles,
J. Seymour,
F. Offner,
A. López-Guillermo,
D. Belada,
L. Xerri,
P. Feugier,
R. Bouabdallah,
J. Catalano,
P. Brice,
D. Caballero,
C. Haioun,
L. Pedersen,
A. Delmer,
D. Simpson,
...
S. Leppa,
P. Soubeyran,
A. Hagenbeek,
O. Casasnovas,
T. Intragumtornchai,
C. Fermé,
Maria Gomes da Silva,
C. Sebban,
A. Lister,
J. Estell,
G. Milone,
A. Sonet,
M. Mendila,
B. Coiffier,
H. Tilly
|
9 |
2011 |
9
🐜
|
|
🐜
|
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
21 auth.
F. Guilhot,
C. Chastang,
M. Michallet,
A. Guerci,
J. Harousseau,
F. Maloisel,
R. Bouabdallah,
D. Guyotat,
N. Cheron,
F. Nicolini,
...
J. Abgrall,
J. Tanzer,
Maurice Navarro,
D. Bordessoule,
P. Morice,
N. Ifrah,
H. Rochant,
J. Vilque,
M. Delain,
F. Bauters,
J. Guilhot
|
9 |
1997 |
9
🐜
|
|
🐜
|
Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).
14 auth.
N. Mounier,
J. Brière,
C. Gisselbrecht,
J. Emile,
P. Lederlin,
C. Sebban,
F. Berger,
A. Bosly,
P. Morel,
H. Tilly,
...
R. Bouabdallah,
F. Reyes,
P. Gaulard,
B. Coiffier
|
9 |
2003 |
9
🐜
|
|
🐜
|
Treatment of older patients with mantle-cell lymphoma.
34 auth.
H. Kluin-Nelemans,
E. Hoster,
O. Hermine,
J. Walewski,
M. Trněný,
C. Geisler,
S. Stilgenbauer,
C. Thieblemont,
U. Vehling‐Kaiser,
J. Doorduijn,
B. Coiffier,
R. Forstpointner,
H. Tilly,
Lothar Kanz,
P. Feugier,
...
M. Szymczyk,
M. Hallek,
Stephan Kremers,
G. Lepeu,
L. Sanhes,
J. Zijlstra,
R. Bouabdallah,
P. Lugtenburg,
M. Macro,
M. Pfreundschuh,
V. Procházka,
F. Raimondo,
V. Ribrag,
M. Uppenkamp,
M. André,
W. Klapper,
W. Hiddemann,
M. Unterhalt,
M. Dreyling
|
8 |
2012 |
8
🐜
|
|
🐜
|
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
26 auth.
M. André,
T. Girinsky,
M. Federico,
O. Reman,
C. Fortpied,
M. Gotti,
O. Casasnovas,
P. Brice,
R. W. van der Maazen,
A. Re,
V. Edeline,
C. Fermé,
G. V. van Imhoff,
F. Merli,
R. Bouabdallah,
...
C. Sebban,
L. Specht,
A. Stamatoullas,
R. Delarue,
V. Fiaccadori,
M. Bellei,
T. Raveloarivahy,
A. Versari,
M. Hutchings,
M. Meignan,
J. Raemaekers
|
8 |
2017 |
8
🐜
|
|
🐜
|
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.
13 auth.
T. Witzig,
J. Vose,
P. Zinzani,
C. Reeder,
R. Buckstein,
J. Polikoff,
R. Bouabdallah,
C. Haioun,
H. Tilly,
P. Guo,
...
D. Pietronigro,
A. Ervin‐Haynes,
M. Czuczman
|
8 |
2011 |
8
🐜
|
|
🐜
|
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
29 auth.
J. Raemaekers,
M. André,
M. Federico,
T. Girinsky,
R. Oumedaly,
E. Brusamolino,
P. Brice,
C. Fermé,
R. W. van der Maazen,
M. Gotti,
R. Bouabdallah,
C. Sebban,
Y. Lievens,
A. Re,
A. Stamatoullas,
...
F. Morschhauser,
P. Lugtenburg,
E. Abruzzese,
P. Olivier,
R. Casasnovas,
G. V. van Imhoff,
T. Raveloarivahy,
M. Bellei,
Thierry van der Borght,
S. Bardet,
A. Versari,
M. Hutchings,
M. Meignan,
C. Fortpied
|
8 |
2014 |
8
🐜
|
|
🐜
|
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.
17 auth.
G. Salles,
N. Mounier,
S. de Guibert,
F. Morschhauser,
C. Doyen,
J. Rossi,
C. Haioun,
P. Brice,
B. Mahé,
R. Bouabdallah,
...
B. Audhuy,
C. Fermé,
C. Dartigeas,
P. Feugier,
C. Sebban,
L. Xerri,
C. Foussard
|
8 |
2008 |
8
🐜
|
|
🐜
|
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
15 auth.
N. Mourad,
N. Mounier,
J. Brière,
E. Raffoux,
A. Delmer,
A. Feller,
C. Meijer,
Jean-François Emile,
R. Bouabdallah,
A. Bosly,
...
J. Diebold,
C. Haioun,
B. Coiffier,
C. Gisselbrecht,
P. Gaulard
|
8 |
2008 |
8
🐜
|
|
🐜
|
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
14 auth.
J. Blay,
T. Conroy,
C. Chevreau,
A. Thyss,
N. Quesnel,
H. Eghbali,
R. Bouabdallah,
B. Coiffier,
J. Wagner,
A. L. Mevel,
...
D. Dramais-Marcel,
E. Baumelou,
F. Chauvin,
P. Biron
|
8 |
1998 |
8
🐜
|
